Form 8-K - Current report:
SEC Accession No. 0001808665-25-000034
Filing Date
2025-11-10
Accepted
2025-11-10 16:13:04
Documents
14
Period of Report
2025-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asrt-20251110.htm   iXBRL 8-K 33368
2 EX-99.1 asrtq32025earningsreleasee.htm EX-99.1 348087
6 image0a06a.jpg GRAPHIC 3999
  Complete submission text file 0001808665-25-000034.txt   536029

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20251110.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20251110_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20251110_pre.xml EX-101.PRE 13052
16 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20251110_htm.xml XML 2824
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 251466338
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)